ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Krystal Biotech Inc

Krystal Biotech Inc (KRYS)

153.24
-2.51
(-1.61%)
마감 17 2월 6:00AM
153.24
-0.37
(-0.24%)
시간외 거래: 6:03AM

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
105.0046.5050.400.0048.450.000.00 %00-
110.0041.5045.5040.0043.500.000.00 %00-
115.0036.5040.500.0038.500.000.00 %00-
120.0032.0036.000.0034.000.000.00 %00-
125.0027.5031.400.0029.450.000.00 %00-
130.0023.1026.900.0025.000.000.00 %00-
135.0019.0022.900.0020.950.000.00 %00-
140.0015.1018.900.0017.000.000.00 %00-
145.0011.5015.2015.5013.350.000.00 %02-
150.008.0012.306.0010.150.000.00 %01,002-
155.005.509.707.437.602.7759.44 %65915/02/2025
160.003.507.605.785.550.346.25 %651215/02/2025
165.002.006.303.924.150.000.00 %035-
170.001.106.006.003.550.000.00 %0151-
175.000.404.802.102.600.000.00 %015-
180.000.504.800.652.650.000.00 %020-
185.000.054.001.202.0250.000.00 %016-
190.000.052.900.501.4750.000.00 %028-
195.000.152.051.911.100.000.00 %017-
200.000.611.900.611.2550.000.00 %035-

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
105.001.751.901.751.8250.000.00 %01-
110.000.004.700.000.000.000.00 %00-
115.003.001.003.002.000.000.00 %01-
120.000.004.800.000.000.000.00 %00-
125.000.105.000.982.55-0.71-42.01 %65115/02/2025
130.000.305.001.602.650.000.00 %01,003-
135.000.505.000.002.750.000.00 %00-
140.001.906.001.653.950.000.00 %010-
145.003.507.202.755.350.000.00 %01-
150.005.409.507.227.454.72188.80 %661,00115/02/2025
155.007.6012.007.509.803.3681.16 %1414/02/2025
160.0011.0015.003.8013.000.000.00 %0504-
165.0014.5018.504.3016.500.000.00 %01-
170.0018.0022.5014.2020.250.000.00 %05-
175.0022.5026.5014.0024.500.000.00 %03-
180.0026.5031.0023.8528.750.000.00 %022-
185.0031.0035.0022.8433.000.000.00 %00-
190.0036.0040.0029.1638.000.000.00 %01-
195.0040.5044.500.0042.500.000.00 %00-
200.0045.7049.500.0047.600.000.00 %00-

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 6.02
(133.33%)
101.64M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
WRDWeRide Inc
US$ 31.4877
(83.39%)
20.57M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.67M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
134.88M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
US$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
189.56M

KRYS Discussion

게시물 보기
Monksdream Monksdream 4 월 전
KRYS. Under $200
👍️0
Monksdream Monksdream 7 월 전
KRYS new 52 week high
👍️0
Monksdream Monksdream 9 월 전
KRYS 10Q due 5/6
👍️0
Monksdream Monksdream 10 월 전
KRYS over $30
👍️0
Monksdream Monksdream 11 월 전
KRYS new 52 week high
👍️0
Monksdream Monksdream 2 년 전
From Cathie Wood
A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
Research Associate
Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.
👍️0
wiredawg wiredawg 3 년 전
Moving nicely today...
👍️0
wiredawg wiredawg 3 년 전
Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?
👍️0
wiredawg wiredawg 3 년 전
In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

👍️0
wiredawg wiredawg 3 년 전
30 Nov Tues releases this PR during evening after market close:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering
👍️0
wiredawg wiredawg 3 년 전
29 Nov Mon after market closes release this PR:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering
👍️0
wiredawg wiredawg 3 년 전
29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal
👍️0
wiredawg wiredawg 3 년 전
This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.
👍️0
wiredawg wiredawg 3 년 전
Holding well so far, why the pretty hard drop?
👍️0
wiredawg wiredawg 3 년 전
Why are you surprised? Serious question, not being impudent...
👍️0
rynlrt rynlrt 3 년 전
200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens
👍️0
Fofo812 Fofo812 3 년 전
Surprised it held up this long
👍️0
crudeoil24 crudeoil24 3 년 전
Large tutes holdings. Some taking huge gains before years end.
👍️0
rynlrt rynlrt 3 년 전
Not sure this kind of gain is sustainable. May see a big pullback
👍️0
Fofo812 Fofo812 3 년 전
3rd post
👍️0
crudeoil24 crudeoil24 3 년 전
Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.
👍️0
Trophy Trophy 5 년 전
..
👍️0